[1]. Chamine, I., & Oken, B. S. (2016). Aroma effects on physiologic and cognitive function following acute stress: A mechanism investigation. Journal of Alternative and Complementary Medicine, 22(8), 713–721.
[2]. Buckle, J. (1999). Use of aromatherapy as a complementary treatment for chronic pain. Alternative Therapies in Health and Medicine, 5(1), 42.
[3]. Cooke, B., & Ernst, E. (2000). Aromatherapy: a systematic review. British Journal of General Practice, 50(460), 493–496.
]4]. دهقان، معصومه؛ فرخندهزاده، محبوبه؛ نیمروزی، مجید (۱۳۹۹). القـانون و جایگاه عطردرمانی در پیشگیری از ابتلا به بیماریها یا مداوای آنها بهعنوان روشی درمانگر، دین و سلامت، دوره ۸، شماره ۲، صص ۷۱-۷۹.
[5]. Scuteri, D., Morrone, L. A., Rombolà, L., Avato, P. R., Bilia, A. R., Corasaniti, M. T., et al. (2017). Aromatherapy and aromatic plants for the treatment of behavioural and psychological symptoms of dementia in patients with Alzheimer’s disease: clinical evidence and possible mechanisms. Evidence-Based Complementary and Alternative Medicine, 2017, Article ID 9416305.
[6]. Cornelissen, F. M., Markert, G., Deutsch, G., Antonara, M., Faaij, N., Bartelink, I., et al. (2023). Explaining blood–brain barrier permeability of small molecules by integrated analysis of different transport mechanisms. Journal of Medicinal Chemistry, 66(11), 7253–7267.
[7]. Bakkali, F., Averbeck, S., Averbeck, D., & Idaomar, M. (2008). Biological effects of essential oils–a review. Food and Chemical Toxicology, 46(2), 446–475.
[8]. Maggio, A., Rosselli, S., & Bruno, M. (2016). Essential oils and pure volatile compounds as potential drugs in Alzheimer’s disease therapy: An updated review of the literature. Current Pharmaceutical Design, 22(28), 4011–4027.
[9]. Tseng, Y.-H. (2005). Aromatherapy in nursing practice. Hu Li Za Zhi, 52(1), 11–15.
[10]. Buck, L., & Axel, R. (1991). A novel multigene family may encode odorant receptors: A molecular basis for odor recognition. Cell, 65(1), 175–187.
[11]. Herz, R. S. (2009). A naturalistic analysis of autobiographical memories triggered by olfactory, visual and auditory stimuli. Chemical Senses, 29(3), 217–224.
[12]. Sowndhararajan, K., & Kim, S. (2016). Influence of fragrances on human psychophysiological activity: With special reference to human electroencephalographic response. Scientia Pharmaceutica, 84(4), 724–752.
[13]. Buck, L. B. (2004). Unraveling the sense of smell. Les Prix Nobel, 2004, 267–283.
[14]. Malnic, B., Godfrey, P. A., & Buck, L. B. (2004). The human olfactory receptor gene family. Proceedings of the National Academy of Sciences, 101(8), 2584–2589.
[15]. Einer-Jensen, N., & Hunter, R. H. F. (2005). Counter-current transfer in reproductive biology. Reproduction, 129(1), 9–18.
[16]. Dong, J., Shang, Y., Inthavong, K., Chan, H.-K., & Tu, J. (2018). Numerical comparison of nasal aerosol administration systems for efficient nose-to-brain drug delivery. Pharmaceutical Research, 35(1), 1–12.
[17]. Frey II, W. H. (2016). Intranasal drug delivery bypasses the blood–brain barrier. Neurology Reviews, 24(1), 40–41.
[18]. Boesveldt, S., & Parma, V. (2021). The importance of the olfactory system in human well-being, through nutrition and social behavior. Cell and Tissue Research, 383(3), 559–567.
[19]. Boesveldt, S., Postma, E. M., Boak, D., Welge-Luessen, A., Schöpf, V., Mainland, J. D., et al. (2017). Anosmia-a clinical review. Chemical Senses, 42(7), 513–523.
[20]. Zou, X., Liu, X., Lu, C., Jin, X., He, B., Liao, Y., et al. (2024). Traditional Chinese medicine for post-viral olfactory dysfunction: A systematic review. Integrative Medicine Research, 13, Article 101045.
[21]. Smith, J., Lee, R., Patel, M., Nguyen, T., Garcia, L., & Johnson, P. (2019). Complementary medicine: A review. Journal of Integrative Medicine, 17(4), 250–260.
[22]. Jones, P., & Brown, S. (2020). Aromatherapy and olfactory stimulation in mental health care: A systematic review. Complementary Therapies in Medicine, 52, 102485.
[23]. Williams, C., Thompson, D., & Garcia, M. (2018). The effects of music therapy on stress and anxiety in clinical populations: A meta-analysis. Journal of Music Therapy, 55(3), 243–270.
[24]. Haider, R. (2021). Potential treatment option for COVID-19 related Anosmia-Chamomile (Matricaria chamomilla) extract nasal irrigation: A literature review. International Journal of Medical Science and Diagnosis Research, 5.
[25]. Klein, J., Yan, X., Johnson, A., Tomljanovic, Z., Zou, J., Polly, K., et al. (2021). Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer’s disease. Journal of Alzheimer’s Disease, 80(3), 1051–1065.
[26]. Chen, Y.-N., & Kostka, J. K. (2024). Beyond anosmia: olfactory dysfunction as a common denominator in neurodegenerative and neurodevelopmental disorders. Frontiers in Neuroscience, 18, Article 1502779.
[27]. Berube, S., Demers, C., Bussière, N., Cloutier, F., Pek, V., Chen, A., et al. (2023). Olfactory training impacts olfactory dysfunction induced by COVID-19: a pilot study. ORL, 85(1), 57–66.
[28]. Anbaraki, A., Dindar, Z., Mousavi-Jarrahi, Z., Ghasemi, A., Moeini, Z., Evini, M., et al. (2024). The novel anti-fibrillary effects of volatile compounds α-asarone and β-caryophyllene on tau protein: Towards promising therapeutic agents for Alzheimer’s disease. International Journal of Biological Macromolecules, 271, 132401.
[29]. Irandoust, M., Anbaraki, A., Dindar, Z., Ghasemi, A., Saboury, A. A., Rayati, S., & Seyedarabi, A. (2025). Concentration‐Based Analysis of Metal‐Induced Tau Fibrillar versus non‐fibrillar Aggregation: Implications for Neurotoxicity in Alzheimer's Disease. ChemistryOpen, e202400493.
[30]. Dindar, Z., Anbaraki, A., Hosseini, S. S., Harati, Z., Bahrami, A., Balalaie, S., et al. (2025). The use of natural volatile compounds on the fibrillation domain of amyloid beta (GSNKGAIIGLM)─ Towards promising agents to combat Alzheimer’s disease. ACS Chemical Neuroscience.
[31]. Moeini, Z., Seraj, Z., Zohoorian Abootorabi, T., Ashrafi-Kooshk, M., Riazi, G., Saboury, A. A., et al. (2022). Unravelling the novel effects of three volatile compounds in preventing fibril formation of disease-related tau and α-synuclein proteins-Towards identifying candidate aromatic substances for treating neurodegenerative diseases. Frontiers in Pharmacology, 13, 793727.
